Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Two Sacubitril/Valsartan 97 mg/103 mg Formulations in Healthy Thai Subjects (Fasting)
TCTR20230207002Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sacubitril + valsartan in heart failure (HF) (2 arms), sponsored by Dr. Reddy's Laboratories. Started May 2023; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on TCTR20230207002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230207002.